Skip to main content

Table 5 Multivariate analysis

From: The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

  Time to progression
Variable HR 95% CI p value*
Age 1.521 1.105–2.093 0.010
Gender 1.313 0.939–1.837 0.111
Performance 2.079 0.743–5.816 0.163
Operation 1.143 0.763–1.713 0.516
Stage 0.941 0.763–1.161 0.571
Lauren type 1.035 0.857–1.250 0.720
Number of metastasis 1.375 1.129–1.674 0.002
−634 G/C polymorphism 1.497 1.074–2.088 0.017
  1. *by cox regression test.
  2. VEGF: vascular endothelial growth factor.